InvestorsHub55d agoneutral
Novo Nordisk Adopts Novo as Everyday Operating Name and Introduces New Cultural FrameworkNotícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
105last 24h
3127last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
The Wall Street Journal57d agoneutral
Heart Disease, a Historic Strength for Big Pharma, Becomes a WeaknessGuruFocus.com58d agobearish
Morgan Stanley Downgrades Novo Nordisk to Sell on Lilly CompetitionGuruFocus.com58d agobearish
Novo Nordisk Stock Plunges on Morgan Stanley Downgrade Warns of Semaglutide Patent CliffYahoo Finance61d agoneutral
Why the CEO of Wegovy maker Novo Nordisk isn't yet sold on the peptide crazeYahoo Finance61d agoneutral
Why CEO of Wegovy maker Novo Nordisk isn't sold yet on the peptide crazeMarketWatch64d agobullish
Plastic surgery is booming with boomers. Here’s how to cash in on the antiaging craze.Simply Wall St.65d agoneutral
Novo Nordisk (CPSE:NOVO B) Stock Looks Below Fair Value But Faces Earnings DoubtsGuruFocus.com68d agoneutral
Novo Nordisk Trades Nearly 58% Below GF Value as Wegovy Pill Launches in GermanyBarrons.com73d agobearish
Novo Nordisk Stock Is Downgraded to Sell, and GLP-1s Aren’t the ReasonThe Wall Street Journal73d agobearish
Novo Nordisk Shares Drop as Bank Downgrade Reflects Growth ConcernsInvestor's Business Daily79d agoneutral
Eli Lilly Is In A Race with Novo Nordisk But Its Stock Is The Clear WinnerThe Wall Street Journal81d agoneutral
Novo Nordisk Starts Testing Lower-Doses of Its Wegovy Weight-Loss PillsInvestor's Business Daily81d agoneutral
Eli Lilly, Novo Nordisk Battle It Out In Weight-Loss Pills Market